Examination of International Drug Pricing Policies in Selected Countries Shows Prevalent Government Control over Pricing and Restrictions on Access

Report Extract: The Trump Administration has proposed using its demonstration authority under section 1115A of the Social Security Act to test a method of reimbursement for physician-administered drugs based on prices in 14 countries. The proposal is controversial, raising constitutional questions about the agency’s authority to modify Medicare reimbursement absent congressional action, as well...

Preserving Patient Choice for Affordable Coverage

Galen Institute president Grace-Marie Turner testified before the House Energy and Commerce Committee on Feb. 13 about preserving consumer protections in health insurance while giving consumers more choices of affordable coverage.  She focused on: The Trump administration’s Section 1332 guidance which gives states new authority to help their individual and small group markets heal from...

Preview Of The Coming Medicare For All Debate

The pre-existing condition scare tactics continue. I testified yesterday—as the sole witness called by the Republican minority—during a House Education and Labor Committee hearing on “Examining Threats to Workers with Preexisting Conditions.”   It was the first hearing of the new Congress under the new Chairman Bobby Scott, D-VA, and virtually all members on both sides...